{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:12Z","timestamp":1786118832192,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/coc.0b013e31804b45a9","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T03:01:52Z","timestamp":1191294112000},"page":"520-525","source":"Crossref","is-referenced-by-count":3,"title":["Prostate High Dose Rate Brachytherapy in a Free-Standing Cancer Center Setting"],"prefix":"10.1097","volume":"30","author":[{"given":"Morgan","family":"Tharp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Terry","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Scheidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Serbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Stuhldreher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Vaught","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0360-3016(95)00035-W","article-title":"Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I\/II trial.","volume":"33","author":"Stromberg","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0167-8140(00)00291-7","article-title":"High dose rate prostate brachytherapy: the California Endocurietherapy (CET) Method.","volume":"57","author":"Demanes","year":"2000","journal-title":"Radiother Oncol"},{"key":"R3-11-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0360-3016(01)01758-8","article-title":"Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer.","volume":"52","author":"Galalae","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-11-20210128","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0360-3016(98)00097-2","article-title":"High dose-rate afterloading 192-Iridium prostate brachytherapy: feasibility report.","volume":"41","author":"Mate","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-11-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(97)00121-7","article-title":"Combined treatment with temporary short-term high dose rate Iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma.","volume":"44","author":"Borghede","year":"1997","journal-title":"Radiother Oncol"},{"key":"R6-11-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0167-8140(98)00054-1","article-title":"High-dose rate interstitial with external beam irradiation for localized prostate cancer: results of a prospective trial.","volume":"48","author":"Dinges","year":"1998","journal-title":"Radiother Oncol"},{"key":"R7-11-20210128","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0360-3016(02)02733-5","article-title":"Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer.","volume":"53","author":"Martinez","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-11-20210128","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2004.08.014","article-title":"High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.","volume":"61","author":"Demanes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia: the Measurement Committee of the American Urological Association.","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"R10-11-20210128","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-5347(17)35410-1","article-title":"The use of prostatic specific antigen, clinical stage and Gleason score to predict pathologic stage in men with localized prostate cancer.","volume":"150","author":"Partin","year":"1993","journal-title":"J Urol"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0360-3016(01)01579-6","article-title":"Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.","volume":"50","author":"Pilepich","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-11-20210128","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/jama.284.10.1280","article-title":"Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer.","volume":"284","author":"D'Amico","year":"2000","journal-title":"JAMA"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.","volume":"337","author":"Bolla","year":"1997","journal-title":"N Engl J Med"},{"key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":"Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0302-2838(02)00016-7","article-title":"High dose rate brachytherapy of localized prostate cancer.","volume":"41","author":"Deger","year":"2002","journal-title":"Eur Urol"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/01.ju.0000052720.62999.a9","article-title":"Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.","volume":"169","author":"Martinez","year":"2003","journal-title":"J Urol"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0360-3016(03)00640-0","article-title":"RTOG 94\u201306: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?","volume":"57","author":"Valicenti","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-11-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2003.10.004","article-title":"3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer.","volume":"71","author":"Martin","year":"2004","journal-title":"Radiother Oncol"},{"key":"R19-11-20210128","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/01.ju.0000113299.34404.22","article-title":"High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.","volume":"171","author":"Grills","year":"2004","journal-title":"J Urol"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(02)00408-5","article-title":"Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer.","volume":"66","author":"Pellizzon","year":"2003","journal-title":"Radiother Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0b013e31804b45a9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:49:29Z","timestamp":1786034969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-200710000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e31804b45a9","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}